The HSPB1 Knockout Jurkat Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat T lymphocyte line, engineered for disruption of the HSPB1 gene to enable loss-of-function studies. This polyclonal pool retains heterogeneous editing events across the population, offering a robust model for examining the cellular consequences of HSPB1 ablation without clonal selection. The product is suitable for investigators requiring a physiologically relevant T cell context to interrogate stress-induced signaling, apoptosis, and cytoskeletal dynamics.
The Jurkat host line is a widely used human T lymphocyte cell line established from the peripheral blood of a patient with acute T cell leukemia. It serves as a canonical model for T cell receptor signaling, activation-induced cell death, and leukemogenesis. Jurkat cells exhibit well-characterized responses to oxidative stress, heat shock, and chemotherapeutic agents, making them an appropriate background for studying stress adaptation and drug resistance mechanisms mediated by HSPB1.
HSPB1 (also known as HSP27) is a small heat shock protein that functions as an ATP-independent chaperone and key regulator of apoptosis and actin dynamics. Under stress conditions, p38 MAPK (MAPK14) activates MAPKAPK2, which directly phosphorylates HSPB1 at Ser15, Ser78, and Ser82, promoting its oligomerization and chaperone activity. Phosphorylated HSPB1 stabilizes actin filaments, interacts with DAXX to inhibit Fas-mediated apoptosis, and sequesters cytochrome c and pro-caspase-3, thereby blocking apoptosome formation and caspase activation. Additional interactions with Akt and ??B-crystallin (CRYAB) further enhance its cytoprotective functions. Upstream, HSPB1 expression is transcriptionally regulated by HSF1 upon heat shock and oxidative stress. Thus, HSPB1 operates at a nexus of stress sensing, cytoskeletal remodeling, and cell survival signaling.
In Jurkat T cells, HSPB1 is rapidly phosphorylated following T cell receptor engagement or exposure to stressors such as H2O2, and it contributes to the resistance of leukemic cells to various chemotherapeutics. Disruption of HSPB1 in this background allows precise dissection of its role in T cell apoptosis pathways, particularly the mitochondrial and death receptor routes. The polyclonal knockout population is especially useful for assessing heterogeneity in stress responses and for screening compounds that target HSPB1-dependent survival mechanisms. Moreover, because HSPB1 modulates actin dynamics, the model enables investigation of cytoskeletal rearrangements during lymphocyte activation and migration.
Researchers can employ these cells to assess stress-induced apoptosis by Annexin V staining and flow cytometry, to quantify caspase-3/7 activation, and to analyze HSPB1 phosphorylation status via western blotting. Actin cytoskeleton integrity can be visualized by phalloidin staining, and cell viability under heat shock or oxidative stress can be monitored. The model is also suitable for evaluating the role of HSPB1 in chemoresistance to agents like etoposide or doxorubicin. Gene expression analysis by qPCR can confirm HSPB1 transcript loss. For detailed technical specifications and assistance, please contact Ascent Research.
